PubMed for id: 1186

Year	Number of Results
1994	1
1995	2
1996	2
1997	2
1998	3
1999	2
2001	3
2002	1
2003	4
2004	5
2005	6
2006	8
2007	5
2008	11
2009	7
2010	13
2011	14
2012	10
2013	11
2024	0

1

Id4 promotes senescence and sensitivity to doxorubicin-induced apoptosis in DU145 prostate cancer cells.

Carey JP, Knowell AE, Chinaranagari S, Chaudhary J. Carey JP, et al. Anticancer Res. 2013 Oct;33(10):4271-8. Anticancer Res. 2013. PMID: 24122992 Free PMC article.

2

Epigenetic inactivation of inhibitor of differentiation 4 (Id4) correlates with prostate cancer.

Sharma P, Chinaranagari S, Patel D, Carey J, Chaudhary J. Sharma P, et al. Cancer Med. 2012 Oct;1(2):176-86. doi: 10.1002/cam4.16. Epub 2012 Aug 2. Cancer Med. 2012. PMID: 23342267 Free PMC article.

3

Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis.

Martini M, Cenci T, D'Alessandris GQ, Cesarini V, Cocomazzi A, Ricci-Vitiani L, De Maria R, Pallini R, Larocca LM. Martini M, et al. Cancer. 2013 Mar 1;119(5):1004-12. doi: 10.1002/cncr.27821. Epub 2012 Nov 6. Cancer. 2013. PMID: 23132729 Free article.

4

[Effect of 5-Aza-CdR on biological activity and inhibitor of DNA binding 4 gene expression in human erythroleukemia cell line K562].

Wang LF, Huang S, Huang C, Li CR, Li DJ. Wang LF, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Dec;19(6):1388-92. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011. PMID: 22169289 Chinese.

5

ID4 regulates mammary gland development by suppressing p38MAPK activity.

Dong J, Huang S, Caikovski M, Ji S, McGrath A, Custorio MG, Creighton CJ, Maliakkal P, Bogoslovskaia E, Du Z, Zhang X, Lewis MT, Sablitzky F, Brisken C, Li Y. Dong J, et al. Development. 2011 Dec;138(23):5247-56. doi: 10.1242/dev.069203. Development. 2011. PMID: 22069192 Free PMC article.

6

ID4 is frequently downregulated and partially hypermethylated in prostate cancer.

Vinarskaja A, Goering W, Ingenwerth M, Schulz WA. Vinarskaja A, et al. World J Urol. 2012 Jun;30(3):319-25. doi: 10.1007/s00345-011-0750-8. Epub 2011 Sep 1. World J Urol. 2012. PMID: 21882048

7

[ID4 promoter methylation in acute myeloid leukemia].

Xu RR, Liu F, Cui X, Zhang XW, Wang Y. Xu RR, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Jun;19(3):582-4. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011. PMID: 21729527 Chinese.

8

Parakeratosis in skin is associated with loss of inhibitor of differentiation 4 via promoter methylation.

Ruchusatsawat K, Wongpiyabovorn J, Protjaroen P, Chaipipat M, Shuangshoti S, Thorner PS, Mutirangura A. Ruchusatsawat K, et al. Hum Pathol. 2011 Dec;42(12):1878-87. doi: 10.1016/j.humpath.2011.02.005. Epub 2011 Jun 12. Hum Pathol. 2011. PMID: 21663940

9

[Methylation status of id4 gene promoter in patients with chronic myeloid leukemia].

Wang XR, Kang HY, Cen J, Li YH, Wang LL, Yu L. Wang XR, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Dec;18(6):1402-4. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010. PMID: 21176338 Chinese.

10

Inhibitor of DNA binding 4 (ID4) regulation of adipocyte differentiation and adipose tissue formation in mice.

Murad JM, Place CS, Ran C, Hekmatyar SK, Watson NP, Kauppinen RA, Israel MA. Murad JM, et al. J Biol Chem. 2010 Jul 30;285(31):24164-73. doi: 10.1074/jbc.M110.128744. Epub 2010 May 11. J Biol Chem. 2010. PMID: 20460371 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

100 results

Results by year